Best VCs for Health Technology

34 venture capitalists actively investing in Health Technology.

34
Active VCs
0
Funds
0
Deals
#1Agate Freimane

Founding General Partner

Norrsken VC

Agate backs rapidly scalable businesses where solving a major social or environmental problem improves commercial performance. Her finance, fintech-startup and education experience combines with Norrs

Norrsken VC's live site publishes €1M–€10M early-stage and growth tickets. This is the firm's current range, not Agate's personal check promise; exact initial versus follow-on sizing, ownership and vehicle should be confirmed for each opportunity.
Early StageSeedSeries A
#2Tove Larsson

Founding General Partner

Norrsken VC

Tove backs ambitious European technology companies whose commercial growth directly improves outcomes for people or planet. Her Bain private-equity background and early impact roles add rigorous marke

Norrsken VC currently states €1M–€10M early-stage and growth tickets. This is the firm's range, not Tove's personal promise. Confirm initial ticket, follow-on reserves, ownership and stage with the team.
Early StageSeedSeries A
#3Ilkka Kivimäki

Founding Partner & Advisor of Maki.vc

Maki.vc (Web3)

Ilkka co-built Maki around entrepreneurial DNA, technical depth, non-consensus first-round decisions and Nordic founders with global category ambition. His documented portfolio work spans gaming, smar

Maki Fund III currently states €300K–€3M initial tickets in pre-seed and seed rounds below €5M, with follow-on reserves. This is the active firm's range, not Ilkka's personal or current new-deal authority; his stated remit focuses on existing portfolio companies.
Pre-SeedSeedFirst Institutional Round
#4Nat Turner

Head of Events

Lux Capital

Nat designs the convening layer around Lux's frontier-science and technology network. Her work brings together founders, researchers, executives, investors, journalists and creative leaders in focused

Not applicable to Nat's events role. Lux invests across stages, but no personal allocation authority or check size belongs to this profile. Founder financing pitches should go to Lux's investment team.
Founder and portfolio communityExecutive conveningThought-leadership programming
#5Anna Lundin

Investment Manager

Norrsken VC

Anna combines Norrsken's impact-return mandate with eight years of strategy, operations and international market expansion at Spotify. Her likely value is testing whether an early impact company can t

Norrsken VC currently publishes €1M–€10M early-stage and growth tickets. This is a firm range rather than Anna's personal authority. Confirm geography, initial ticket, ownership, reserves and impact qualification through the firm's pitch process.
Early StageSeedSeries A
#6Douglas Reed

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#7Kim Hodges

Chief Financial Officer

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#8Fred Goldwater

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#9Holden Thorp

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#10Ben Scruggs

Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#11Kseniya Simpson

Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#12Alston Gardner

Special Advisor

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#13Parker Johnson

Head of Investor Relations

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#14Graham Smith

Associate

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#15Declan Devens

Operations Analyst

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#16Lauren P Flickinger

Partner and Fund Manager

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#17Myla Lai-Goldman

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#18Kirkland Hendrickson

Program Manager

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#19Heather Madsen

Operating Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#20John Crumpler

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#21Clay B. Thorp

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#22Kenneth B. Lee, Jr.

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#23Carl Soderstrom

Founding Partner

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

$500K-$2M
Startup and growth capital
#24Clay Heighten

Founding Member

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

$500K-$2M
Startup and growth capital
#25JR Garcia

Partner

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

$500K-$2M
Startup and growth capital
#26Lauren Tyra, PhD

Chief Scientific Officer

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

$500K-$2M
Startup and growth capital
#27Daniel S. Parsley

Managing Partner, GPG Ventures - Houston

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

$500K-$2M
Startup and growth capital
#28John Leader

Principal, Investment Operations

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

$500K-$2M
Startup and growth capital
#29Claire England

Investment Partner

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

$500K-$2M
Startup and growth capital
#30Drew Soderstrom

Head of Investor Relations

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

$500K-$2M
Startup and growth capital
#31João Pedro Roque

Principal

Indico Capital

João evaluates Southern European technology companies through a combined engineering, investment-banking, private-equity and venture lens. The documented firm mandate favors globally ambitious founder

Indico's live technology mandate states mostly Pre-Seed through Series A investments of €500K–€10M, with selective Series B/C participation. This is the firm's range rather than João's personal authority; founders should confirm vehicle, initial ticket and reserves.
Pre-SeedSeedSeries A
#32Rui Jerónimo

Principal

Indico Capital

Rui brings long-running Portuguese institutional venture experience to Indico's early-stage Southern European technology mandate. Public evidence supports a broad rather than narrow personal sector re

Indico currently publishes €500K–€10M technology investments, mostly from Pre-Seed through Series A with selective Series B/C. This is the live firm range, not Rui's personal check authority; exact sizing and vehicle should be confirmed directly.
Pre-SeedSeedSeries A
#33Rui Rodrigues

Partner

Indico Capital

Rui combines venture investing with transaction and corporate-finance discipline. Within Indico's mandate, that supports globally ambitious Southern European technology companies from early validation

Indico's current technology range is €500K–€10M, mostly Pre-Seed through Series A and selectively Series B/C. This is firm-level guidance, not Rui's personal commitment range; founders should confirm the applicable fund, initial size and reserves.
Pre-SeedSeedSeries A
#34Christy Shaffer

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity